143 related articles for article (PubMed ID: 14969830)
1. Isolated hepatic perfusion: a regional therapy for liver cancer.
Yang ZW; Xu GL
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):12-6. PubMed ID: 14969830
[TBL] [Abstract][Full Text] [Related]
2. Isolated liver perfusion for non-resectable liver tumours: a review.
Christoforidis D; Martinet O; Lejeune FJ; Mosimann F
Eur J Surg Oncol; 2002 Dec; 28(8):875-90. PubMed ID: 12477481
[TBL] [Abstract][Full Text] [Related]
3. Recent trends and future perspectives in isolated hepatic perfusion in the treatment of liver tumors.
Rothbarth J; Tollenaar RA; van de Velde CJ
Expert Rev Anticancer Ther; 2006 Apr; 6(4):553-65. PubMed ID: 16613543
[TBL] [Abstract][Full Text] [Related]
4. A phase I study of hyperthermic isolated hepatic perfusion with oxaliplatin in the treatment of unresectable liver metastases from colorectal cancer.
Zeh HJ; Brown CK; Holtzman MP; Egorin MJ; Holleran JL; Potter DM; Bartlett DL
Ann Surg Oncol; 2009 Feb; 16(2):385-94. PubMed ID: 19034580
[TBL] [Abstract][Full Text] [Related]
5. Development of isolated hepatic perfusion for patients who have unresectable hepatic malignancies.
Jones A; Alexander HR
Surg Oncol Clin N Am; 2008 Oct; 17(4):857-76, x. PubMed ID: 18722923
[TBL] [Abstract][Full Text] [Related]
6. Isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: recent trends and perspectives.
Rothbarth J; Tollenaar RA; Schellens JH; Nortier JW; Kool LJ; Kuppen PJ; Mulder GJ; van de Velde CJ
Eur J Cancer; 2004 Aug; 40(12):1812-24. PubMed ID: 15288282
[TBL] [Abstract][Full Text] [Related]
7. Isolated hepatic perfusion chemotherapy for unresectable malignant hepatic tumors.
Ku Y; Tominaga M; Iwasaki T; Fukumoto T; Kuroda Y
Int J Clin Oncol; 2002 Apr; 7(2):82-90. PubMed ID: 12018114
[TBL] [Abstract][Full Text] [Related]
8. Palliative techniques for hepatic cancer.
Ruan DT; Warren RS
Surg Oncol Clin N Am; 2004 Jul; 13(3):505-16, ix. PubMed ID: 15236732
[TBL] [Abstract][Full Text] [Related]
9. Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overview.
Barber FD; Mavligit G; Kurzrock R
Cancer Treat Rev; 2004 Aug; 30(5):425-36. PubMed ID: 15245775
[TBL] [Abstract][Full Text] [Related]
10. Bio-chemotherapeutic strategies and the (dis) utility of hypoxic perfusion of liver, abdomen and pelvis using balloon catheter techniques.
van Ijken MG; van Etten B; Brunstein F; ten Hagen TL; Guetens G; de Wilt JH; de Bruijn EA; Eggermont AM
Eur J Surg Oncol; 2005 Oct; 31(8):807-16. PubMed ID: 15951150
[TBL] [Abstract][Full Text] [Related]
11. The past decade of experience with isolated hepatic perfusion.
Grover A; Alexander HR
Oncologist; 2004; 9(6):653-64. PubMed ID: 15561809
[TBL] [Abstract][Full Text] [Related]
12. Synergistic antitumor effects of histamine plus melphalan in isolated hepatic perfusion for liver metastases.
Brunstein F; Eggermont AM; de Wiel-Ambagtsheer Ga; van Tiel ST; Rens J; ten Hagen TL
Ann Surg Oncol; 2007 Feb; 14(2):795-801. PubMed ID: 17096052
[TBL] [Abstract][Full Text] [Related]
13. Isolated hepatic perfusion for the treatment of patients with advanced liver metastases from pancreatic and gastrointestinal neuroendocrine neoplasms.
Grover AC; Libutti SK; Pingpank JF; Helsabeck C; Beresnev T; Alexander HR
Surgery; 2004 Dec; 136(6):1176-82. PubMed ID: 15657573
[TBL] [Abstract][Full Text] [Related]
14. Isolated hepatic perfusion for the treatment of liver tumors: sunset or sunrise?
Verhoef C; de Wilt JH; ten Hagen TL; Eggermont AM
Surg Oncol Clin N Am; 2008 Oct; 17(4):877-94, xi. PubMed ID: 18722924
[TBL] [Abstract][Full Text] [Related]
15. Endovascular isolated hepatic perfusion under pneumoperitoneum.
Christoforidis D; Antonescu C; Horisberger J; Kosinski M; Mosimann F; Martinet O
Eur J Surg Oncol; 2006 Feb; 32(1):113-20. PubMed ID: 16289717
[TBL] [Abstract][Full Text] [Related]
16. Isolated hypoxic hepatic perfusion (IHHP) using balloon catheter techniques: from laboratory to the clinic towards a percutaneous procedure.
Eggermont AM; van IJken MG; van Etten B; van der Sijp JR; ten Hagen TL; Wiggers T; Oudkerk M; de Boeck G; de Bruijn EA
Hepatogastroenterology; 2000; 47(33):776-81. PubMed ID: 10919031
[TBL] [Abstract][Full Text] [Related]
17. Isolated hepatic perfusion: principles and results.
Facy O; Doussot A; Zinzindohoué F; Holl S; Rat P; Ortega Deballon P
J Visc Surg; 2014 Apr; 151 Suppl 1():S25-32. PubMed ID: 24582276
[TBL] [Abstract][Full Text] [Related]
18. Phase II feasibility study on the combination of two different regional treatment approaches in patients with colorectal "liver-only" metastases: hepatic interstitial brachytherapy plus regional chemotherapy.
Wieners G; Pech M; Hildebrandt B; Peters N; Nicolaou A; Mohnike K; Seidensticker M; Sawicki M; Wust P; Ricke J
Cardiovasc Intervent Radiol; 2009 Sep; 32(5):937-45. PubMed ID: 19472000
[TBL] [Abstract][Full Text] [Related]
19. Outcome analysis of a decade-long experience of isolated hepatic perfusion for unresectable liver metastases at a single institution.
Magge D; Choudry HA; Zeh HJ; Cunningham DE; Steel J; Holtzman MP; Jones HL; Pingpank JF; Bartlett DL; Zureikat AH
Ann Surg; 2014 May; 259(5):953-9. PubMed ID: 24169176
[TBL] [Abstract][Full Text] [Related]
20. Isolated hypoxic hepatic perfusion with orthograde or retrograde flow in patients with irresectable liver metastases using percutaneous balloon catheter techniques: a phase I and II study.
van Etten B; Brunstein F; van IJken MG; Marinelli AW; Verhoef C; van der Sijp JR; Guetens G; de Boeck G; de Bruijn EA; de Wilt JH; Eggermont AM
Ann Surg Oncol; 2004 Jun; 11(6):598-605. PubMed ID: 15172933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
